Researchers develop gut-restricted drug to treat inflammatory bowel disease

A new study of mice and lab-grown human colon «organoids» indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.